Voyager Therapeutics
Maneesha Paranjpe has a diverse range of work experience in the fields of scientific research and data analysis. Maneesha began their career as an intern at Nulife Pharmaceuticals in 2004, before working as a pharmacologist and clinical data analyst at Evolvus Biotech in 2006. In 2008, they became a research assistant at the University of Rhode Island, where they focused on studying the effects of a high cholesterol diet on drug transporter expression and cholesterol gallstone formation in mice.
From 2010 to 2015, Maneesha worked as a senior research technician at Tufts University School of Medicine. During their time there, they investigated the effects of perinatal and peripubertal exposure to the xenoestrogen Bisphenol A (BPA) on the development of obesity and metabolic disorders in mice. Maneesha performed various experiments to analyze the effects of BPA on inflammation, metabolism, and body composition in mice, as well as developed and optimized laboratory techniques for determining inflammation and liver lipid accumulation. Maneesha also conducted glucose tolerance tests and insulin tolerance tests on mice, and performed various molecular and histological analyses.
Since 2016, Maneesha has been working at Voyager Therapeutics, Inc. Maneesha started as a senior research associate and has steadily progressed to roles with increasing responsibility, including senior research associate II, principal research associate, and currently, scientist I. The details of their work in these positions are not provided.
Overall, Maneesha Paranjpe's work experience showcases their expertise in scientific research, data analysis, and laboratory techniques, particularly in the fields of obesity, metabolic disorders, and drug transporter expression.
Maneesha Paranjpe completed their Bachelor of Science degree in Pharmacy from Savitribai Phule Pune University, where they studied from 2002 to 2006. Following their undergraduate studies, they pursued a Master of Science degree in Pharmacology and Toxicology at the University of Rhode Island from 2007 to 2010.
This person is not in the org chart
Voyager Therapeutics
1 followers
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.